📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia. (2026)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2025029302

PubMed Identifier: 40898981

Publication URI: http://europepmc.org/abstract/MED/40898981

Type: Journal Article/Review

Volume: 147

Parent Publication: Blood

Issue: 2

ISSN: 0006-4971